Published in J Mol Biol on March 19, 2010
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. J Lipid Res (2011) 0.96
Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol (2014) 0.89
SorLA complement-type repeat domains protect the amyloid precursor protein against processing. J Biol Chem (2014) 0.89
The RelA nuclear localization signal folds upon binding to IκBα. J Mol Biol (2010) 0.89
A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low-density lipoprotein receptor-related protein). Biochem J (2012) 0.84
Role of an intramolecular contact on lipoprotein uptake by the LDL receptor. Biochim Biophys Acta (2011) 0.82
Quantitative dissection of the binding contributions of ligand lysines of the receptor-associated protein (RAP) to the low density lipoprotein receptor-related protein (LRP1). J Biol Chem (2013) 0.82
Haptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines. Front Cell Neurosci (2014) 0.78
K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells. J Biol Chem (2015) 0.78
Impact of Concanavalin-A-Mediated Cytoskeleton Disruption on Low-Density Lipoprotein Receptor-Related Protein-1 Internalization and Cell Surface Expression in Glioblastomas. Biomark Cancer (2016) 0.77
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke. Ann Clin Transl Neurol (2017) 0.77
High Affinity Binding of the Receptor-associated Protein D1D2 Domains with the Low Density Lipoprotein Receptor-related Protein (LRP1) Involves Bivalent Complex Formation: CRITICAL ROLES OF LYSINES 60 AND 191. J Biol Chem (2016) 0.76
Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets. Sci Rep (2015) 0.76
Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry. J Viruses (2016) 0.75
New horizons for lipoprotein receptors: communication by β-propellers. J Lipid Res (2013) 0.75
Recombinant Expression of the Full-length Ectodomain of LDL Receptor-related Protein 1 (LRP1) Unravels pH-dependent Conformational Changes and the Stoichiometry of Binding with Receptor-associated Protein (RAP). J Biol Chem (2016) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR (1994) 16.20
Version 1.2 of the Crystallography and NMR system. Nat Protoc (2007) 13.01
Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol (1991) 8.38
LRP: a multifunctional scavenger and signaling receptor. J Clin Invest (2001) 5.31
Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res (1984) 4.12
Structure of the LDL receptor extracellular domain at endosomal pH. Science (2002) 4.06
ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics (2006) 3.70
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science (1991) 3.42
Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature (1997) 3.35
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A (1989) 3.26
39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem (1991) 3.17
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat Struct Mol Biol (2004) 2.69
Three-dimensional triple-resonance NMR Spectroscopy of isotopically enriched proteins. 1990. J Magn Reson (2011) 2.58
A simple method for improving protein solubility and long-term stability. J Am Chem Soc (2004) 2.34
Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1 beta in solution. Science (1990) 2.28
An optimized 3D NOESY-HSQC. J Magn Reson B (1996) 2.17
Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem (1979) 2.08
39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J (1995) 1.98
Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A (1982) 1.96
Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol Cell (2006) 1.94
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem (1983) 1.67
Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor. Proc Natl Acad Sci U S A (1995) 1.55
Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem (1980) 1.33
LDL-receptor structure. Calcium cages, acid baths and recycling receptors. Nature (1997) 1.32
Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem (1988) 1.31
Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem (2005) 1.30
Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif. J Mol Biol (2006) 1.27
NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem (2000) 1.24
The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J Biol Chem (1999) 1.23
NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein. J Biol Chem (1999) 1.19
A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Biochemistry (2004) 1.14
Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers. Curr Opin Struct Biol (2007) 1.13
Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1. Biochemistry (2004) 1.11
Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. J Lipid Res (1999) 1.10
The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry (2000) 1.10
Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand. J Lipid Res (2000) 1.09
Identification of residues in alpha-macroglobulins important for binding to the alpha2-macroglobulin receptor/Low density lipoprotein receptor-related protein. J Biol Chem (1996) 1.09
Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor. Biochemistry (2001) 1.08
The low-density lipoprotein receptor: ligands, debates and lore. Curr Opin Struct Biol (2003) 1.08
Solution structure of the sixth LDL-A module of the LDL receptor. Biochemistry (2000) 1.04
Lipid-induced extension of apolipoprotein E helix 4 correlates with low density lipoprotein receptor binding ability. J Biol Chem (2006) 0.95
Effects of lipid interaction on the lysine microenvironments in apolipoprotein E. J Biol Chem (2000) 0.93
Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E. Biochemistry (2010) 0.92
Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP. Biochemistry (2001) 0.92
Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo. J Lipid Res (2001) 0.91
Folding and binding integrity of variants of a prototype ligand-binding module from the LDL receptor possessing multiple alanine substitutions. Biochemistry (2005) 0.87
The structure of receptor-associated protein (RAP). Protein Sci (2007) 0.87
Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode. J Biol Chem (2008) 0.87
All three LDL receptor homology regions of the LDL receptor-related protein bind multiple ligands. Biochemistry (2003) 0.86
Solution structure and dynamics of melanoma inhibitory activity protein. J Biomol NMR (2002) 0.84
The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex. FEBS Lett (2007) 0.83
A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor. J Biol Chem (1994) 0.82
Lipid-bound structure of an apolipoprotein E-derived peptide. J Biol Chem (2003) 0.82
Apolipoprotein E-low density lipoprotein receptor binding: study of protein-protein interaction in rationally selected docked complexes. Proteins (2004) 0.81
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A (2003) 3.77
Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol (2007) 3.43
Localizing frustration in native proteins and protein assemblies. Proc Natl Acad Sci U S A (2007) 2.33
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer (2013) 2.05
Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem (2005) 2.03
Biophysical characterization of the free IkappaBalpha ankyrin repeat domain in solution. Protein Sci (2004) 1.89
Regions of IkappaBalpha that are critical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB. Proc Natl Acad Sci U S A (2006) 1.86
Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J (2008) 1.83
An unexpected twist in viral capsid maturation. Nature (2009) 1.80
Automated extraction of backbone deuteration levels from amide H/2H mass spectrometry experiments. Protein Sci (2006) 1.75
Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med (2008) 1.74
Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J Biol Chem (2004) 1.69
Energy functions for protein design: adjustment with protein-protein complex affinities, models for the unfolded state, and negative design of solubility and specificity. J Mol Biol (2005) 1.67
The energy landscape of modular repeat proteins: topology determines folding mechanism in the ankyrin family. J Mol Biol (2005) 1.60
Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex. J Mol Biol (2006) 1.59
Stabilizing IkappaBalpha by "consensus" design. J Mol Biol (2006) 1.53
Transfer of flexibility between ankyrin repeats in IkappaB* upon formation of the NF-kappaB complex. J Mol Biol (2008) 1.44
On the role of frustration in the energy landscapes of allosteric proteins. Proc Natl Acad Sci U S A (2011) 1.39
Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha. Proc Natl Acad Sci U S A (2009) 1.39
Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol (2006) 1.37
Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol (2006) 1.36
Amide H/2H exchange reveals communication between the cAMP and catalytic subunit-binding sites in the R(I)alpha subunit of protein kinase A. J Mol Biol (2002) 1.36
Pre-folding IkappaBalpha alters control of NF-kappaB signaling. J Mol Biol (2008) 1.35
Epitope mapping of a monoclonal antibody against human thrombin by H/D-exchange mass spectrometry reveals selection of a diverse sequence in a highly conserved protein. Protein Sci (2002) 1.35
Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proc Natl Acad Sci U S A (2012) 1.33
Folding landscapes of ankyrin repeat proteins: experiments meet theory. Curr Opin Struct Biol (2008) 1.31
Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol (2008) 1.30
Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell (2002) 1.29
Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry (2010) 1.25
The energy landscapes of repeat-containing proteins: topology, cooperativity, and the folding funnels of one-dimensional architectures. PLoS Comput Biol (2008) 1.25
Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J Biol Chem (2005) 1.21
An improved grafting technique for mature Arabidopsis plants demonstrates long-distance shoot-to-root transport of phytochelatins in Arabidopsis. Plant Physiol (2006) 1.21
Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry. J Biol Chem (2006) 1.20
Enhanced conformational space sampling improves the prediction of chemical shifts in proteins. J Am Chem Soc (2010) 1.18
An object-oriented library for computational protein design. J Comput Chem (2007) 1.17
Energy functions for protein design I: efficient and accurate continuum electrostatics and solvation. Protein Sci (2004) 1.17
Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface. J Biol Chem (2006) 1.16
Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. PLoS One (2010) 1.15
The IkappaBalpha/NF-kappaB complex has two hot spots, one at either end of the interface. Protein Sci (2008) 1.15
Solvent accessibility of protein surfaces by amide H/2H exchange MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom (2006) 1.15
Functional dynamics of the folded ankyrin repeats of I kappa B alpha revealed by nuclear magnetic resonance. Biochemistry (2009) 1.14
Identification of the protein kinase A regulatory RIalpha-catalytic subunit interface by amide H/2H exchange and protein docking. Proc Natl Acad Sci U S A (2003) 1.12
Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J Biol Chem (2006) 1.12
Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1. Biochemistry (2004) 1.11
Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci (2007) 1.11
Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Adv Protein Chem (2004) 1.10
Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics (2009) 1.07
Visualization of the nanospring dynamics of the IkappaBalpha ankyrin repeat domain in real time. Proc Natl Acad Sci U S A (2011) 1.06
Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem (2008) 1.06
Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation. J Mol Biol (2002) 1.05
Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. Structure (2011) 1.05
Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib. Blood (2010) 1.04
Allosteric changes in solvent accessibility observed in thrombin upon active site occupation. Biochemistry (2004) 1.04
Thrombomodulin tightens the thrombin active site loops to promote protein C activation. Biochemistry (2005) 1.04
Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). Mol Med (2012) 1.04
Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface. J Mol Biol (2008) 1.03
Critical salt bridges guide capsid assembly, stability, and maturation behavior in bacteriophage HK97. Mol Cell Proteomics (2010) 1.01
Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol (2007) 1.01
Direct observation of a transient ternary complex during IκBα-mediated dissociation of NF-κB from DNA. Proc Natl Acad Sci U S A (2013) 0.98
The dynamic structure of thrombin in solution. Biophys J (2012) 0.98
A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis. Mol Cancer (2010) 0.97
Formation of the pyridazine natural product azamerone by biosynthetic rearrangement of an aryl diazoketone. Angew Chem Int Ed Engl (2009) 0.97
Induced fit, folding, and recognition of the NF-kappaB-nuclear localization signals by IkappaBalpha and IkappaBbeta. J Mol Biol (2006) 0.97
Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. Blood (2012) 0.97
Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry. Biochemistry (2003) 0.96
Structural and biochemical characterization of the interaction between KPC-2 beta-lactamase and beta-lactamase inhibitor protein. Biochemistry (2009) 0.96
ARS5 is a component of the 26S proteasome complex, and negatively regulates thiol biosynthesis and arsenic tolerance in Arabidopsis. Plant J (2009) 0.95
Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol (2011) 0.95
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma. J Lipid Res (2013) 0.95
HK97 maturation studied by crystallography and H/2H exchange reveals the structural basis for exothermic particle transitions. J Mol Biol (2010) 0.94
The plastic landscape of repeat proteins. Proc Natl Acad Sci U S A (2007) 0.94
Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1. Protein Expr Purif (2009) 0.93
Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain. J Biol Chem (2008) 0.93
TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8. J Immunol (2014) 0.93
Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E. Biochemistry (2010) 0.92
Methods for studying transmembrane peptides in bicelles: consequences of hydrophobic mismatch and peptide sequence. J Magn Reson (2002) 0.92
Chapter 4. Interactions of chemokines with glycosaminoglycans. Methods Enzymol (2009) 0.92
Prediction of native-state hydrogen exchange from perfectly funneled energy landscapes. J Am Chem Soc (2011) 0.92
NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27. J Biol Chem (2010) 0.92
Discrete kinetic models from funneled energy landscape simulations. PLoS One (2012) 0.91
Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles. Protein Sci (2004) 0.91
Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration. Lab Invest (2004) 0.91
Folding kinetics of the cooperatively folded subdomain of the IκBα ankyrin repeat domain. J Mol Biol (2011) 0.90
The RelA nuclear localization signal folds upon binding to IκBα. J Mol Biol (2010) 0.89
Emerging concepts and approaches for chemokine-receptor drug discovery. Expert Opin Drug Discov (2010) 0.89
A rapid and efficient way to obtain modified chemokines for functional and biophysical studies. Cytokine (2011) 0.89
Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A (2003) 0.89
Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Biochemistry (2011) 0.88
R-subunit isoform specificity in protein kinase A: distinct features of protein interfaces in PKA types I and II by amide H/2H exchange mass spectrometry. J Mol Biol (2007) 0.88
Chemokines bind to sulfatides as revealed by surface plasmon resonance. Biochim Biophys Acta (2005) 0.88
The structure, dynamics, and binding of the LA45 module pair of the low-density lipoprotein receptor suggest an important role for LA4 in ligand release. Biochemistry (2011) 0.87
Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function. J Med Chem (2011) 0.87
The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization. J Biol Chem (2013) 0.87
NMR structures reveal how oxidation inactivates thrombomodulin. Biochemistry (2003) 0.87
Correlated motions and residual frustration in thrombin. J Phys Chem B (2013) 0.87
Predicted disorder-to-order transition mutations in IκBα disrupt function. Phys Chem Chem Phys (2014) 0.87
Role of disorder in IκB-NFκB interaction. IUBMB Life (2012) 0.86